MARK2 and Peutz-Jeghers syndrome: LKB1, a serine-threonine kinase, is a bona fide tumor suppressor mutationally inactivated in many sporadic cancers [35] and Peutz-Jeghers syndrome, a rare disease associated high risk of gastrointestinal cancers [36].